Package 42291-509-01

{"route": ["ORAL"], "spl_id": "485f9eb1-6531-c47c-e063-6394a90ae32c", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["13AFD7670Q"], "rxcui": ["96304", "198150"], "spl_set_id": ["e7a50a67-9653-463e-8c85-315b53f460c8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-509-01)", "package_ndc": "42291-509-01", "marketing_start_date": "20220322"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (42291-509-50)", "package_ndc": "42291-509-50", "marketing_start_date": "20220322"}], "brand_name": "Primidone", "product_id": "42291-509_485f9eb1-6531-c47c-e063-6394a90ae32c", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "42291-509", "generic_name": "Primidone", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Primidone", "active_ingredients": [{"name": "PRIMIDONE", "strength": "50 mg/1"}], "application_number": "ANDA040866", "marketing_category": "ANDA", "marketing_start_date": "20220322", "listing_expiration_date": "20271231"}